Omalizumab Cuts Red-Meat Allergy Reactions
Omalizumab Cuts Red-Meat Allergy Reactions
Omalizumab Cuts Red-Meat Allergy Reactions
Key points
اہم نکات
मुख्य बातें
- None of 64 alpha-gal patients needed epinephrine for a food reaction while taking omalizumab, and 95% said their reactions became fewer or less severe, a new study found.
- Before treatment, 81% of the patients had suffered anaphylaxis and more than half had needed epinephrine, but on the drug about one in three could eat some or all red meat again.
- The study, presented at the American College of Allergy, Asthma and Immunology meeting, looked at patients treated between April 2022 and November 2025.
- None of 64 alpha-gal patients needed epinephrine for a food reaction while taking omalizumab, and 95% said their reactions became fewer or less severe, a new study found.
- Before treatment, 81% of the patients had suffered anaphylaxis and more than half had needed epinephrine, but on the drug about one in three could eat some or all red meat again.
- The study, presented at the American College of Allergy, Asthma and Immunology meeting, looked at patients treated between April 2022 and November 2025.
- None of 64 alpha-gal patients needed epinephrine for a food reaction while taking omalizumab, and 95% said their reactions became fewer or less severe, a new study found.
- Before treatment, 81% of the patients had suffered anaphylaxis and more than half had needed epinephrine, but on the drug about one in three could eat some or all red meat again.
- The study, presented at the American College of Allergy, Asthma and Immunology meeting, looked at patients treated between April 2022 and November 2025.
None of 64 alpha-gal patients needed epinephrine for a food reaction while taking omalizumab, and 95% said their reactions became fewer or less severe, a new study found. Before treatment, 81% of the patients had suffered anaphylaxis and more than half had needed epinephrine, but on the drug about one in three could eat some or all red meat again. The study, presented at the American College of Allergy, Asthma and Immunology meeting, looked at patients treated between April 2022 and November 2025. Alpha-gal syndrome follows a Lone Star tick bite and causes delayed allergic reactions to beef, pork and lamb. Omalizumab is already used for asthma, food allergies and hives; side effects in the study were mostly mild, including joint pain, and only two patients stopped the drug.
None of 64 alpha-gal patients needed epinephrine for a food reaction while taking omalizumab, and 95% said their reactions became fewer or less severe, a new study found. Before treatment, 81% of the patients had suffered anaphylaxis and more than half had needed epinephrine, but on the drug about one in three could eat some or all red meat again. The study, presented at the American College of Allergy, Asthma and Immunology meeting, looked at patients treated between April 2022 and November 2025. Alpha-gal syndrome follows a Lone Star tick bite and causes delayed allergic reactions to beef, pork and lamb. Omalizumab is already used for asthma, food allergies and hives; side effects in the study were mostly mild, including joint pain, and only two patients stopped the drug.
None of 64 alpha-gal patients needed epinephrine for a food reaction while taking omalizumab, and 95% said their reactions became fewer or less severe, a new study found. Before treatment, 81% of the patients had suffered anaphylaxis and more than half had needed epinephrine, but on the drug about one in three could eat some or all red meat again. The study, presented at the American College of Allergy, Asthma and Immunology meeting, looked at patients treated between April 2022 and November 2025. Alpha-gal syndrome follows a Lone Star tick bite and causes delayed allergic reactions to beef, pork and lamb. Omalizumab is already used for asthma, food allergies and hives; side effects in the study were mostly mild, including joint pain, and only two patients stopped the drug.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।